Junson Capital is a global investment management firm and family office that focuses on long-term value creation across diversified portfolios. The firm specializes in real estate, private equity, and capital markets, with investments also extending to venture capital in sectors like life sciences and high tech.
60% of their portfolio is in Healthcare. They made 2 investments in the last 12 months. Their most common stage is series-b (60% of deals). Average disclosed round size is $53.2M (across 4 rounds with reported amounts).
Portfolio
5
Fund Size
$5B
Top Stage
Series B
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Full-Life Technologies | Series C | $77M | Sep 2025 |
| Full-Life Technologies | Series C | $50M | Sep 2025 |
| Full-Life Technologies | Series B | $47.3M | Jan 2024 |
 Allotex Inc. | Series B | — | Nov 2023 |
 BridGene Biosciences | Series B | $38.5M | Jul 2022 |
Top Co-Investors
Prosperity7 Ventures3 shared
Summer Capital3 shared
Chengwei Capital2 shared
Plaisance Capital Management2 shared
Sky9 Capital1 shared
Hongshan1 shared
HSG1 shared
Last updated: 18 March 2026